If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirecta Plus Regulatory News (DCTA)

  • This share is currently suspended. It was suspended at a price of 6.75
  • There is currently no data for DCTA

Agreement with Iterchimica

14 Apr 2020 07:00

RNS Number : 4660J
Directa Plus PLC
14 April 2020
 

14 April 2020

 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE EU MARKET ABUSE REGULATION (596/2014). UPON THE PUBLICATION OF THE ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

Directa Plus plc

("Directa Plus" or the "Company")

 

Agreement with Iterchimica to Supply G+ Graphene for Use in Asphalts

 

Directa Plus (AIM: DCTA), a producer and supplier of graphene-based products for use in consumer and industrial markets, is pleased to announce an agreement ("the Agreement") with partner Iterchimica, an Italian based world leader in products that enhance asphalt performance, for the supply of a special grade of the Company's G+ graphene product, known as ITC1. The G+ product is the differentiating component of Gipave®, an asphalt supermodifier developed by Directa Plus and Iterchimica and follows successful trials in Italy and the UK.

 

The Agreement provides for the exclusive supply of the G+ graphene product to Iterchimica in the asphalt and bitumen sector worldwide and is for an initial duration of three years. The Agreement allows the partners to take advantage of what they believe are significant existing business opportunities in Italy, the UK and the United States. The first order for the G+ ITC1 nanoplatelets for asphalt for the production of Gipave® has now been received from Iterchimica. Results from the UK trials in November 2019 are expected shortly and we are seeing growing interest from asphalt companies in the UK but also now from the USA.

 

Gipave® was developed by Iterchimica with the support of Directa Plus and resulted from a four year research programme with a patent filed in 2017. In an initial trial in Italy, it was confirmed as providing significant benefits compared to traditional asphalt in all areas tested: service life, resistance to the passage of vehicles, resistance to deformation and permanent plastic deformation. In addition, once laid, asphalt with Gipave® can be 100 per cent recycled, which reduces the extraction of new materials from quarries and first-use bitumen. 

 

Commenting, Giulio Cesareo, Founder and CEO of Directa Plus, said: "The potential of Gipave® to potentially triple the life of roads and runways is attracting significant worldwide interest from the construction industry. Its ecological benefits will also help countries to meet their carbon reduction obligations and free up resources at a time when all national and regional governments need financial assistance to fight the current COVID-19 pandemic."

 

Federica Giannattasio, Iterchimica CEO, added: "This agreement confirms and continues a cooperation we started four years ago. We now hope to work together on the large-scale roll-out of Gipave® and following the first trial section laid in Oxfordshire, we hope the UK will be among the leaders in adopting graphene technology for road pavements."

 

 

This announcement has been released by Giulio Cesareo, Chief Executive, on behalf of the Company.

 

For further information please visit http://www.directa-plus.com/ or contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO

 

Marco Ferrari, CFO

 

 

 

Cantor Fitzgerald Europe (Nominated Adviser and Joint Broker)

+44 20 7894 7000

Rick Thompson, Philip Davies, Will Goode (Corporate Finance)

 

Caspar Shand Kydd (Sales)

 

 

 

N+1 Singer (Joint Broker)

+44 20 7496 3069

Mark Taylor, Lauren Kettle, Mia Gardner

Tavistock (Financial PR and IR)

+44 20 7920 3150

Simon Hudson, Edward Lee, Barnaby Hayward

 

 

About Directa Plus

Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+ products). In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+ products. All our products are hypoallergenic, non-toxic and sustainably produced.

 

About Iterchimica

Iterchimica, an Italian based world leader in products that enhance both asphalt pavements performance and the laying of road surfaces in order to increase safety, environmental sustainability, and efficiency.

http://www.iterchimica.it/en/

 

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRSFLFWDESSEDL
Date   Source Headline
18th Oct 201911:36 amRNSResult of Open Offer, and GM, Issue of Equity
30th Sep 20192:21 pmRNSAcquisition, Placing and Open Offer
30th Sep 20192:21 pmRNSHalf-year Report
10th Sep 20197:00 amRNSNew Textile Membrane Patent Granted
6th Aug 20198:29 amRNSHolding(s) in Company
29th Jul 20197:00 amRNSAward of Oil Decontamination and Recovery Contract
22nd Jul 20197:00 amRNSHolding(s) in Company
4th Jul 20197:00 amRNSUS Patent Grant for Liquid G+
27th Jun 20197:00 amRNSGrant of US Patent
26th Jun 20199:47 amRNSHolding(s) in Company
18th Jun 20191:36 pmRNSResult of AGM
18th Jun 20197:00 amRNSAGM Statement
17th Jun 20197:00 amRNSHolding(s) in Company
28th May 20197:00 amRNSDirector/PDMR Shareholding
23rd May 20197:00 amRNSNew patent grants
23rd May 20197:00 amRNSPosting of Annual Report and Notice of AGM
7th May 20197:00 amRNSCo-operation agreement with Alfredo Grassi S.p.A.
17th Apr 20197:00 amRNSFinal Results for the Year to 31 December 2018
1st Apr 20197:00 amRNSSuccessful First Road Surface Trial Results
4th Mar 20197:00 amRNS3 Year Exclusive Agreement with Loro Piana
6th Feb 20197:00 amRNSUS National Graphene Association Appointment
31st Jan 20194:41 pmRNSHolding(s) in Company
31st Jan 20199:05 amRNSSecond Price Monitoring Extn
31st Jan 20199:00 amRNSPrice Monitoring Extension
30th Jan 20193:45 pmRNSHolding(s) in Company
30th Jan 201911:00 amRNSHolding(s) in Company
30th Jan 201911:00 amRNSHolding(s) in Company
30th Jan 201911:00 amRNSHolding(s) in Company
8th Jan 201911:58 amRNSResult of General Meeting and Total Voting Rights
7th Jan 20191:00 pmRNSResults of Open Offer
13th Dec 20187:00 amRNSAnnouncement of Open Offer
12th Dec 20183:30 pmRNSResults of Placing
12th Dec 201811:30 amRNSProposed Placing to raise a minimum of £3 million
5th Dec 20187:00 amRNSDirecta Plus to present at Denim Première Vision
29th Nov 20187:00 amRNSCollaboration Agreement with Ambienthesis S.p.A.
23rd Nov 20184:00 pmRNSDirecta Plus to present at Mello London
23rd Nov 20187:00 amRNSEnvironmental Sale and Participation in Trial
22nd Nov 20187:00 amRNSTrading Update
30th Oct 20189:15 amRNSFurther Agreement with Arvind, Launch of G+ Jeans
23rd Oct 20187:00 amRNSSignificant Textiles Order
28th Sep 201812:55 pmRNSDirector/PDMR Shareholding
26th Sep 20182:24 pmRNSReplacement: Director/PDMR Shareholding
26th Sep 201812:52 pmRNSDirector/PDMR Shareholding
26th Sep 20187:00 amRNSWorld's First Road Surface Containing Graphene
25th Sep 20187:00 amRNSHalf-year Report
31st Jul 20187:00 amRNSAppointment of N+1 Singer as Joint Broker
9th Jul 201810:00 amRNSOakley and Bioracer launch Graphene Plus jersey
4th Jul 20187:00 amRNSSecond significant order from Alfredo Grassi
18th Jun 20184:28 pmRNSResult of AGM
18th Jun 20187:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.